Ykrita Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 3.75 M
as on 18-07-2024
- Paid Up Capital ₹ 1.78 M
as on 18-07-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -124.61%
(FY 2022)
- Ebitda -116.25%
(FY 2022)
- Net Worth 1396.32%
(FY 2022)
- Total Assets 251.25%
(FY 2022)
About Ykrita Lifesciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.75 M and a paid-up capital of Rs 1.78 M, as per Ministry of Corporate Affairs (MCA) records.
Shivkumar Janardhanan, Mahesh Gopasetty, and Kalidevapura Reddy serve as directors at the Company.
- CIN/LLPIN
U74999KA2020PTC134284
- Company No.
134284
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2020
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bengaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ykrita Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivkumar Janardhanan  | Director | 23-May-2020 | Current |
| Kalidevapura Reddy | Director | 23-May-2020 | Current |
| Mahesh Gopasetty | Director | 23-May-2020 | Current |
Financial Performance and Corporate Structure Insights of Ykrita Lifesciences.
Ykrita Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 124.61% decrease in profit. The company's net worth Soared by an impressive increase of 1396.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ykrita Lifesciences?
In 2021, Ykrita Lifesciences had a public holding of 16.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Srushti Engineering Innovations Private LimitedActive 10 years 6 monthsKalidevapura Reddy is a mutual person
Sunnysideup Advertising India Private LimitedActive 17 years 7 monthsShivkumar Janardhanan is a mutual person
Licorne Business Consulting & Advisory L LpActive 5 years 5 monthsShivkumar Janardhanan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ykrita Lifesciences?
Unlock and access historical data on people associated with Ykrita Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ykrita Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ykrita Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
